Revision as of 22:37, 31 August 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report errors or [[user talk:CheMoB← Previous edit |
Latest revision as of 03:22, 15 April 2024 edit undoJamesray1 (talk | contribs)169 editsNo edit summaryTags: Mobile edit Mobile web edit |
(46 intermediate revisions by 34 users not shown) |
Line 1: |
Line 1: |
|
|
{{Short description|Chemical compound}} |
|
{{Drugbox |
|
{{Drugbox |
|
|
| Verifiedfields = changed |
⚫ |
| verifiedrevid = 443861106 |
|
|
|
| Watchedfields = changed |
⚫ |
| IUPAC_name = 6,7-dimethoxy-3-(6-methyl-5,6,7,8-tetrahydrodioxoloisoquinolin-5-yl)-2-benzofuran-1(3''H'')-one |
|
|
⚫ |
| verifiedrevid = 447739670 |
⚫ |
| image = Hydrastine.PNG |
|
|
⚫ |
| IUPAC_name = 6,7-Dimethoxy-3-(6-methyl-5,6,7,8-tetrahydrodioxoloisoquinolin-5-yl)-2-benzofuran-1(3''H'')-one |
|
⚫ |
| image = Hydrastine.svg |
|
| width = 150 |
|
| width = 150 |
|
|
|
|
Line 9: |
Line 12: |
|
| pregnancy_category = |
|
| pregnancy_category = |
|
| legal_status = |
|
| legal_status = |
|
| routes_of_administration = |
|
| routes_of_administration = |
|
|
|
|
|
<!--Pharmacokinetic data--> |
|
<!--Pharmacokinetic data--> |
Line 18: |
Line 21: |
|
|
|
|
|
<!--Identifiers--> |
|
<!--Identifiers--> |
|
|
| CAS_number_Ref = {{cascite|correct|??}} |
|
| CAS_number = 118-08-1 |
|
| CAS_number = 118-08-1 |
|
| ATC_prefix = none |
|
| ATC_prefix = none |
Line 25: |
Line 29: |
|
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
| DrugBank = |
|
| DrugBank = |
|
|
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|
|
| ChEMBL = 497942 |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID = 171234 |
|
| ChemSpiderID = 171234 |
Line 32: |
Line 38: |
|
<!--Chemical data--> |
|
<!--Chemical data--> |
|
| C=21 | H=21 | N=1 | O=6 |
|
| C=21 | H=21 | N=1 | O=6 |
|
| molecular_weight = 383.395 g/mol |
|
|
| smiles = O=C2O(c1ccc(OC)c(OC)c12)5N(C)CCc4c5cc3OCOc3c4 |
|
| smiles = O=C2O(c1ccc(OC)c(OC)c12)5N(C)CCc4c5cc3OCOc3c4 |
|
| InChI = 1/C21H21NO6/c1-22-7-6-11-8-15-16(27-10-26-15)9-13(11)18(22)19-12-4-5-14(24-2)20(25-3)17(12)21(23)28-19/h4-5,8-9,18-19H,6-7,10H2,1-3H3/t18-,19+/m1/s1 |
|
|
| InChIKey = JZUTXVTYJDCMDU-MOPGFXCFBB |
|
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChI = 1S/C21H21NO6/c1-22-7-6-11-8-15-16(27-10-26-15)9-13(11)18(22)19-12-4-5-14(24-2)20(25-3)17(12)21(23)28-19/h4-5,8-9,18-19H,6-7,10H2,1-3H3/t18-,19+/m1/s1 |
|
| StdInChI = 1S/C21H21NO6/c1-22-7-6-11-8-15-16(27-10-26-15)9-13(11)18(22)19-12-4-5-14(24-2)20(25-3)17(12)21(23)28-19/h4-5,8-9,18-19H,6-7,10H2,1-3H3/t18-,19+/m1/s1 |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey = JZUTXVTYJDCMDU-MOPGFXCFSA-N |
|
| StdInChIKey = JZUTXVTYJDCMDU-MOPGFXCFSA-N |
|
|
| melting_point = 132 |
|
}} |
|
}} |
|
|
|
|
|
'''Hydrastine''' is a natural ] which was discovered in 1851 by ].<ref>{{citation|journal=American Journal of Pharmacy|year=1851|page=112}}</ref> Hydrolysis of hydrastine yields ], which was patented by ] as a ] drug<ref>{{citation|title=Römpp CD|publisher=Georg Thieme Verlag|year=2006}}</ref> during the 1910s. |
|
'''Hydrastine''' is an ] ] which was discovered in 1851 by ].<ref>{{cite journal | vauthors = Perrins JD | title = On Hydrastine, an Alkaloid Occurring in Hydrastis Canadensis. | date = July 1862 | journal = Pharmaceutical Journal: A Weekly Record of Pharmacy and Allied Sciences|url=https://books.google.com/books?id=IusKAAAAYAAJ&pg=PA547|year=1862|publisher=J. Churchill|pages=547–}}</ref> ] of hydrastine yields ], which was patented by ] as a ] drug<ref>{{citation|title=Römpp CD|publisher=Georg Thieme Verlag|year=2006}}</ref> during the 1910s. It is present in '']'' (thus the name) and other plants of the family ]. |
|
|
|
|
|
|
==Total synthesis== |
|
It is naturally present in '']'' (thus the name) and other plants of the ] family. |
|
|
|
|
|
|
|
The first attempt for the ] of hydrastine was reported by ] and co-workers<ref name="HopePyman1931">{{cite journal| vauthors = Hope E, Pyman FL, Remfry FG, Robinson R |title=XXXI.—A synthesis of hydrastine. Part I|journal=J. Chem. Soc.|year=1931|pages=236–247|issn=0368-1769| doi=10.1039/JR9310000236}}</ref> in 1931. Following studies<ref name="HaworthPinder1950">{{cite journal| vauthors = Haworth RD, Pinder AR, Robinson R |title=Synthesis of Hydrastine|journal=Nature|volume=165|issue=4196|year=1950|pages=529|issn=0028-0836|doi=10.1038/165529a0|bibcode=1950Natur.165..529H|s2cid=4198366|doi-access=free}}</ref><ref name="HaworthPinder1950B">{{cite journal| vauthors = Haworth RD, Pinder AR |title=360. A new route to the phthalide-isoquinoline bases, and a synthesis of (–)-hydrastine|journal=J. Chem. Soc.|year=1950|pages=1776–1780|issn=0368-1769|doi=10.1039/JR9500001776}}</ref> where the synthesis of the key lactonic amide intermediate (structure 4 in figure) was the most troublesome, the major breakthrough was achieved in 1981 when J. R. Falck and co-workers<ref name="FalckManna1981">{{cite journal| vauthors = Falck JR, Manna S |author1-link=John R. Falck |title=An intramolecular passerini reaction: Synthesis of hydrastine.|journal=Tetrahedron Letters|volume=22|issue=7|year=1981|pages=619–620|issn=0040-4039|doi=10.1016/S0040-4039(01)92504-3}}</ref> reported a four-step total synthesis of hydrastine from simple starting materials. The key step in the Falck synthesis was using a ] to construct the lactonic amide intermediate 4. |
⚫ |
==References== |
|
|
|
:] |
|
{{reflist}} |
|
|
|
Starting from a simple phenylbromide variant 1, alkylation reaction with lithium methylisocyanide gives the ] intermediate 2. Reacting isocyanide intermediate 2 with opianic acid 3 initiated the intramolecular Passerini reaction to give the key lactonic amide intermediate 4. The tetrahydro-isoquinolin ring was formed by first a ring-closure reaction under dehydration conditions using ] and then a catalyzed hydrogenation using PtO2 as the catalyst. Finally, hydrastine was synthesized by installing the N-methyl group via ] reaction with ]. |
|
|
|
|
|
|
== See also == |
⚫ |
] |
|
|
|
* ] (very similar in structure) |
|
] |
|
|
] |
|
|
] |
|
|
] |
|
|
|
|
|
|
⚫ |
== References == |
|
|
{{Reflist|2}} |
|
|
|
|
|
|
== External links == |
|
{{Blood-drug-stub}} |
|
|
|
* {{cite EB1911|wstitle=Hydrastine |volume=14|page=34}} |
|
{{Biochem-stub}} |
|
|
|
|
|
|
|
{{GABAergics}} |
|
] |
|
|
|
|
|
|
] |
|
|
] |
|
⚫ |
] |
|
|
] |